GSK completes acquisition of Human Genome Sciences
3 August 2012 | By GlaxoSmithKline
GlaxoSmithKline has completed its acquisition of Human Genome Sciences for US$3.6 billion...
List view / Grid view
3 August 2012 | By GlaxoSmithKline
GlaxoSmithKline has completed its acquisition of Human Genome Sciences for US$3.6 billion...
30 July 2012 | By GlaxoSmithKline
GSK announced the results of its initial tender offer for all outstanding shares of HGS...
16 July 2012 | By GlaxoSmithKline
GSK to acquire full ownership of BENLYSTA®, albiglutide and darapladib...
29 June 2012 | By GlaxoSmithKline
Expiration is after HGS process bid deadline of 16 July...
15 June 2012 | By GlaxoSmithKline
GSK has received a renewed invitation from Human Genome Sciences’...
8 June 2012 | By GlaxoSmithKline
GSK has extended its tender offer to acquire all of the outstanding shares of HGS...
1 June 2012 | By GlaxoSmithKline
GSK has clearance under the U.S. anti-trust laws to acquire HGS...